Læknaneminn - 01.10.1995, Qupperneq 102

100 ARUM EFTIR PASTEUR
orsök hafa reynst vera smitsjúkdómar. Má þar
nefna hermannaveiki (Legionnaires disease) sem
reyndist vera af völdum Legionellapneumophila
og maga- og skeifugarnasár sem reyndust vera af
völdum Helicobacterpylori. Með nýrri þekkingu
er hægt að lækna þessa sjúkdóma. I töflu 3 er
listi yfir sjúkdóma og sýkla sem fundist hafa á
síðustu árum. Líklegt er að fleiri sjúkdómar eigi
eftir að reynast vera smitsjúkdómar. Vaxandi
þekking og tækni í sameindalíffræði gera okkur
nú kleift að finna örverur sem er að finna í litlu
magni og erfitt eða ómögulegt er að rækta. Lengi
hafa menn talið líklegt að alvarlegir sjúkdómar
eins og iktsýki, sarco-idosis og Crohns
sjúkdómur kunni að vera smitsjúkdómar.
Nýlegar rannsóknir benda einnig til þess að
bakterían Chlamydia pneumoniae eigi þátt i
kransæðasjúkdómum(lO). Það erþví ljós að enn
er mikið starf óunnið í sýklafræði, bæði hvað
varðar sýklalyfjaónæmi og “nýja smitsjúkdóma”.
FRAMTÍÐIN
Vaxandi sýklalyíjaónæmi og vandamál
tengd þeim
Nýjir smitsjúkdómar greindir með
sameindalíffræðilegum aðferðum
Leit og prófun nýrra sýklalyfja
Þróun og prófun á nýjum bóluefnum
Meiri áhersla á sýkingavarnir og
forvarnir
HEIMILDIR.
1. De Kruif P. Bakteríuveiðar. Þýðing Boga Ólafssonar. Reykjavík: Hið
íslenzka þjóðvinafélag, 1935.
2. Microsoft-corporation. Encarta. Redmond, WA: Microsoft corporation,
1994.
3. Fleury H. Institut Pasteur - Towards a new century. Paris: Institut
Pasteur, 1987:
4. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report
on the Rockefeller University Workshop. New England Journal of
Medicine 1994;330( 17): 1247-51.
5. Kristinsson KG. [Multiresistant bacteria in a Scandinavian perspective].
[Review] [Swedish]. Nordisk Medicin 1995; 110(2):42-4.
6. Armstrong D, Neu H, Peterson LR, Tomasz A. The prospects of
treatment failure in the chemotherapy of infectious diseases in the
1990s. Microbial Drug Resistance 1995; 1(1): 1-4.
7. Kristinsson KG, Hjalmarsdottir MA, Steingrimsson O. Increasing
penicillin resistance in pneumococci in Iceland [letter]. Lancet
1992;339(8809): 1606-7.
8. Kristinsson KG. Epidemiology of penicillin resistant pneumococci in
Iceland. Microbial Drug Resistance 1995; 1(2).
9. Kristinsson KG, Hjálmarsdóttir MÁ, Gudnason T. Epidemiology of
penicillin resistant pneumococci in Iceland - Hope for the future?
ICAAC. San Francisco: ASM, 1995.
10. Campbell LA, O’Brien ER, Cappuccio AL, et al. Detection of
Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.
Journal oflnfectious Diseases 1995;171:585-588.
11. Satcher D. Emerging infections: getting ahead of the curve. Emerging
Infectious Diseases 1995; 1 (1): 1 -6.
12. Bisliop RF, Davidson GP, Holmes II I, Ruck BJ. Virus particles in
epithelial cells of duodenal mucosa from children with acute non-
bacterial gastroenteritis. Lancet 1973;2:1281-1283.
13. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in
human sera. Lancet 1975;1:72-73.
14. Nime FA, Burek JD, Page DL, Holscher MA, Yardley JH. Acute
enterocolitis in a human being infected with the protozoan
Cryptosporidium. Gastroenterology 1976;70:592-598.
15. Johnson KM, Webb PA, Lange JV, Murphy FA. Isolation and partial
characterization of a new virus causing acute haemorrhagic fever in
Zaire. Lancet 1977;1:569-571.
16. McDade JE, Shepard CC, Fraser DW, Tsai TR. Redus MA, Dowdle
QR. Laboratory investigation team. Legionnaires’ disease. 2: Isolation
of a bacterium and demonstration of its role in other respiratory
disease. New England Journal of Medicine 1977;297:1197-1203.
17. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of
Korean hemorrhagic fever. Journal of Infectious Diseases
1978;137:298-308.
18. Skirrow MB. Campylobacter enteritis: a new disease. British Medical
Journal 1977;2:9-11.
19. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC.
Detection and isolation of type C retrovirus particles from fresh and
cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
Proceedings of the National Academy of Sciences 1980;77:7415-7419.
20. Schlievert PM, Shands KN, Gan BB. Schmid GP, Nishimura RD.
Identification and characterization of an exotoxin from Staphylococcus
auresu associated with toxic shock syndrome. Journal of Infectious
Diseases 1981;143:509-516.
21. Riley LW, Remis RS, Helgerson SD, al e. Hemorrhagic colitis
associated with a rare Escherichia coli serotype. New England Journal
ofMedicine 1983;308:681-685.
22. Kalyanaraman S, Sarangadharan MG, Poiesz B, Ruscetti FW, Gallo
RC. Immunological properties of a type C retrovirus isolated from
cultured human T-lymphoma cells and comparison to other mammalian
retroviruses. Journal of Virology 1981;38:906-915.
23. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis
JP. Lyme disease - a tick-borne spirochetosis? Science 1982;216:1317-
1319.
24. Barré-Sinoussi F, Chermann JC, Rey F, et. al. Isolation of a T-
lymphotropic retrovirus from a patient at risk for acquired immune
deficiency syndrome. Science 1983;220:868-871.
25. Yamanishi K, Okuno T, Shiraki K, et al. Identification of human
herpesvirus-6 as a causal agent for exanthem subitum. Lancet
1988;1:1065-1067.
26. Dawson JE, Anderson BE, Fishbein DB, et al. Isolation and
characterization of an Ehrlichia sp. from a patient diagnosed with
human ehrlichiosis. Journal ofClinical Microbiology 1991 ;29:2741 -
2745.
27. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M.
Isolation of a cDNA clone derived from a blood-borne non-A, non-B
viral hepatitis genome. Science 1989;244:359-361.
28. Salas R, de Manzione N, Tesh RB, et al. Venezuelan hemorrhagic fever.
Lancet 1991;338:1033-1036.
29. World-Health-Organization. Epidemic diarrhea due to Vibrio cholerae
non-01. Weekly Epidemiological Records 1993;68:141-142.
92
LÆKNANEMINN 2,tbl. 1995 48. árg.